personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Translational Scientist.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to Solutions/product profiles
digital magazine subscription
The Translational Scientist
Welcome to the December issue of The Translational Scientist! This month, we look at a multiple sclerosis drug being repurposed in the fight against microbial resistance, and cover the opposite of innovation: exnovation. We also sit down with Ron Heeren, Director of Maastricht MultiModal Molecular Imaging Institute (M4I), Distinguished Professor and Limburg Chair at Maastricht University, The Netherlands. Stay tuned for more of the latest news and views in translational science throughout the month…